Svendsen Laboratory

The mission of the Svendsen Laboratory is to study neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Huntington’s disease (HD), spinal muscular atrophy (SMA), Parkinson’s disease (PD) and Allan-Herndon-Dudley syndrome (AHDS) using stem cells as a disease treatment, as well as a tool for modeling these diseases in vitro. Clive Svendsen, PhD has significant experience in studying these diseases over the last twenty years and is merging his experience with the use of leading-edge technologies, such as inducible pluripotent stem cells (iPS cells).

Svendsen also pursues many collaborative efforts with other researchers interested in the use of neural progenitor cells for the treatment of stroke and macular degeneration.

The Svendsen Laboratory is affiliated with the Regenerative Medicine Institute and Department of Biomedical Sciences.